School of Medicine
Showing 121-140 of 224 Results
-
Masashi Miyauchi
Basic Life Research Scientist, Medicine - Med/Hematology
BioMasashi Miyauchi, MD, PhD, is a physician-scientist specializing in hematology, oncology, immunology, and stem cell biology, with over a decade of experience in clinical hematology and oncology. Dr. Miyauchi's academic career commenced at Kyoto University, where he obtained his MD in Medicine. He furthered his expertise with a PhD in Internal Medicine from The University of Tokyo, Graduate School of Medicine. Following his comprehensive clinical training and professional appointments at The University of Tokyo Hospital, Dr. Miyauchi embarked on a postdoctoral journey at Stanford University in the Nakauchi lab, starting in July 2019.
Dr. Miyauchi's clinical training is extensive, including a Senior Residency in Internal Medicine and a Clinical Fellowship in Hematology and Oncology at The University of Tokyo Hospital. This period was complemented by his participation in a Cancer Professional Training Plan. After completing his clinical fellowship, Dr. Miyauchi has served in various pivotal roles at The University of Tokyo Hospital and The University of Tokyo. His positions as a clinically-focused Project Assistant Professor and Assistant Professor in the Department of Hematology and Oncology have enabled him to contribute significantly to pioneering research and education for the next wave of medical professionals.
In his PhD research, Dr. Miyauchi specialized in the disease modeling of cancers and cancer stem cells, employing cancer patient-specific induced pluripotent stem cells (iPSCs). His work with iPSCs notably includes scalable ex vivo manufacturing of human neutrophils. In his postdoctoral research under the guidance of Dr. Hiromitsu Nakauchi in Genetics at Stanford, Dr. Miyauchi has been concentrating on developing a stable hematopoietic stem cell (HSC) expansion system in both mouse and human models. His research is focused on exploring the potential applications of this expansion system, underlining his commitment to advancing the fields of stem cell biology, regenerative medicine and oncology. -
Namu Park
Postdoctoral Scholar, Biomedical Informatics
BioDr. Park is a Postdoctoral Scholar at the Division of Computational Medicine at Stanford University, where he is co-advised by Dr. Tina Hernandez-Boussard and Dr. Yair Bannet. He received his PhD in Biomedical and Health Informatics from the University of Washington.
His research focuses on clinical natural language processing and large language models for healthcare. He develops clinically grounded information extraction methods and evaluation frameworks that reflect real-world clinical workflows. His work examines how large language models can be aligned with clinical reasoning and rigorously evaluated for safe and effective deployment in health systems.
Through interdisciplinary collaboration, Dr. Park aims to bridge advances in foundation models with measurable clinical impact, emphasizing reliability, transparency, and scalability in AI-driven healthcare applications. -
Preethy Parthiban
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioMy research centers on how the innate immune system shapes tissue remodeling in health and disease. During my PhD, I uncovered a key role for resident macrophages in driving cardiac fibrosis, identifying a macrophage-derived chemokine that directly activates cardiac fibroblasts. Building on this foundation, my postdoctoral work at Stanford focuses on neutrophil–macrophage crosstalk in disrupted alveolarization in neonatal mice and patients. By integrating cellular, molecular, and translational approaches, I aim to define how innate immune pathways orchestrate extracellular matrix remodeling. Ultimately, my goal is to identify critical therapeutic targets that improve outcomes in ECM-related diseases.
-
Deanna Pepin
Postdoctoral Scholar, Pathology
BioHey there! I was born in the small town of Selkirk, Manitoba, but lived most of my life in Edmonton, Alberta. I completed my Bachelor of Science at Kings University, focusing on biology and did undergrad research on Pink Pigmented Facultative Methylotrophs - bacteria that degrade petrochemicals. Following graduation, I became a Research Technician with Exciton Technologies Inc., a research and development company producing silver-based wound care products for treating infections. In 2016, I joined Dr. Benjamin Willing’s lab in Agriculture, Food, and Nutritional Sciences at the University of Alberta and completed a Master of Science focusing on how certain husbandry changes impact the development of the gastrointestinal microbiota, Salmonella infection resistance, and immune response in broiler production. In 2024, I completed my PhD in the department of Microbiology & Immunology at UBC, working with Dr. Carolina Tropini to understand the impact of osmotic stress on the gut microbiome.
-
Javier Perez-Garcia
Postdoctoral Scholar, Epidemiology
BioJavier Perez-Garcia is a postdoctoral scholar in the Department of Epidemiology and Population Health at Stanford University. His research has been focused on the integration of multi-omic data (e.g., genomics, epigenomics, transcriptomics, and microbiome) to identify potential biomarkers of treatment response for complex diseases like asthma. His research background includes experience both in molecular biology techniques (e.g., DNA extraction and sequencing libraries preparation) and bioinformatic analyses (e.g., processing of raw omic data, association studies at genomic scale, or multi-omic integration through machine learning and quantitative trait loci analyses). He holds a Ph.D. in Health Sciences and a B.Sc. in Pharmacy from the University of La Laguna (Spain).
